Advertisement

Topics

Pulse Biosciences to Host Investor Conference Call on March 14, 2017

16:46 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Pulse Biosciences, Inc., (Nasdaq: PLSE) a medical technology company developing a proprietary therapeutic tissue treatment platform based on Nano-Pulse Stimulation (NPS), will host its first quarter investor conference call on M...

Other Sources for this Article

Investors:
Pulse Biosciences, Inc.
Darrin Uecker, President and Chief Executive Officer
IR@pulsebiosciences.com
or
Media:
Sam Brown, Inc.
Hannah Hurdle, 805-601-5331
hannahhurdle@sambrown.com

NEXT ARTICLE

More From BioPortfolio on "Pulse Biosciences to Host Investor Conference Call on March 14, 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...